USD 0.1
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -162.83 Million USD | -97.76% |
2022 | -82.34 Million USD | -4093.21% |
2021 | 2.06 Million USD | 108.64% |
2020 | -23.87 Million USD | -93.37% |
2019 | -12.34 Million USD | 59.87% |
2018 | -30.77 Million USD | -202.59% |
2017 | 29.99 Million USD | 1063.87% |
2016 | 2.57 Million USD | 158.04% |
2015 | -4.44 Million USD | 58.16% |
2014 | -10.61 Million USD | -123.55% |
2013 | -4.74 Million USD | 27.5% |
2012 | -6.54 Million USD | 34.92% |
2011 | -10.06 Million USD | 4.34% |
2010 | -10.51 Million USD | 40.51% |
2009 | -17.67 Million USD | -516.21% |
2008 | -2.86 Million USD | -127.31% |
2007 | 10.5 Million USD | 394.77% |
2006 | 2.12 Million USD | -84.62% |
2005 | 13.8 Million USD | 267.05% |
2004 | 3.76 Million USD | 21.06% |
2003 | 3.1 Million USD | 370.61% |
2002 | 660 Thousand USD | -71.78% |
2001 | 2.33 Million USD | 125.55% |
2000 | 1.03 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -22.77 Million USD | 49.64% |
2024 Q2 | -24.68 Million USD | -8.35% |
2023 FY | -162.83 Million USD | -97.76% |
2023 Q3 | -44.27 Million USD | -39.91% |
2023 Q1 | -25.01 Million USD | -221.21% |
2023 Q2 | -31.64 Million USD | -26.5% |
2023 Q4 | -45.23 Million USD | -2.16% |
2022 Q4 | -7.78 Million USD | 35.82% |
2022 FY | -82.34 Million USD | -4093.21% |
2022 Q1 | -15.14 Million USD | -284.8% |
2022 Q2 | -47.27 Million USD | -212.22% |
2022 Q3 | -12.13 Million USD | 74.33% |
2021 Q1 | -359 Thousand USD | -116.41% |
2021 FY | 2.06 Million USD | 108.64% |
2021 Q3 | -1.39 Million USD | -117.94% |
2021 Q4 | -3.93 Million USD | -183.09% |
2021 Q2 | 7.74 Million USD | 2257.66% |
2020 FY | -23.87 Million USD | -93.37% |
2020 Q1 | -12.41 Million USD | -494.54% |
2020 Q2 | -11.39 Million USD | 8.22% |
2020 Q4 | 2.18 Million USD | 196.94% |
2020 Q3 | -2.25 Million USD | 80.19% |
2019 Q2 | 588 Thousand USD | 107.15% |
2019 Q1 | -8.22 Million USD | 68.74% |
2019 Q4 | -2.08 Million USD | 20.55% |
2019 Q3 | -2.62 Million USD | -546.94% |
2019 FY | -12.34 Million USD | 59.87% |
2018 Q3 | -873 Thousand USD | 44.47% |
2018 Q1 | -2.03 Million USD | -108.88% |
2018 Q2 | -1.57 Million USD | 22.64% |
2018 FY | -30.77 Million USD | -202.59% |
2018 Q4 | -26.29 Million USD | -2911.8% |
2017 Q2 | 1.94 Million USD | 290.51% |
2017 Q4 | 22.88 Million USD | 269.75% |
2017 Q3 | 6.18 Million USD | 217.82% |
2017 FY | 29.99 Million USD | 1063.87% |
2017 Q1 | -1.02 Million USD | -124.26% |
2016 Q1 | -2.05 Million USD | -200.05% |
2016 Q2 | -1.22 Million USD | 40.08% |
2016 Q4 | 4.21 Million USD | 156.27% |
2016 Q3 | 1.64 Million USD | 233.77% |
2016 FY | 2.57 Million USD | 158.04% |
2015 Q4 | 2.05 Million USD | 314.21% |
2015 FY | -4.44 Million USD | 58.16% |
2015 Q3 | -957 Thousand USD | 49.34% |
2015 Q2 | -1.88 Million USD | 48.16% |
2015 Q1 | -3.64 Million USD | -124.25% |
2014 Q1 | -3.61 Million USD | -1198.56% |
2014 Q2 | -2.74 Million USD | 24.07% |
2014 Q3 | -2.63 Million USD | 3.83% |
2014 Q4 | -1.62 Million USD | 38.35% |
2014 FY | -10.61 Million USD | -123.55% |
2013 Q1 | -2.16 Million USD | -300.84% |
2013 FY | -4.74 Million USD | 27.5% |
2013 Q4 | -278 Thousand USD | 83.33% |
2013 Q3 | -1.66 Million USD | -161.44% |
2013 Q2 | -638 Thousand USD | 70.5% |
2012 Q3 | -892 Thousand USD | 39.15% |
2012 FY | -6.54 Million USD | 34.92% |
2012 Q1 | -5.26 Million USD | -493.8% |
2012 Q2 | -1.46 Million USD | 72.17% |
2012 Q4 | 1.07 Million USD | 220.74% |
2011 Q3 | -2.86 Million USD | -16.57% |
2011 Q2 | -2.45 Million USD | 36.29% |
2011 Q1 | -3.85 Million USD | -201.17% |
2011 FY | -10.06 Million USD | 4.34% |
2011 Q4 | -887 Thousand USD | 69.02% |
2010 Q4 | -1.28 Million USD | 63.0% |
2010 FY | -10.51 Million USD | 40.51% |
2010 Q1 | -2.01 Million USD | -28928.57% |
2010 Q2 | -3.76 Million USD | -86.37% |
2010 Q3 | -3.45 Million USD | 8.03% |
2009 Q1 | -1.82 Million USD | -677.87% |
2009 Q2 | -2.36 Million USD | -29.32% |
2009 Q4 | 7000.00 USD | 100.05% |
2009 Q3 | -13.49 Million USD | -470.81% |
2009 FY | -17.67 Million USD | -516.21% |
2008 Q1 | -542 Thousand USD | -114.96% |
2008 Q3 | -2.75 Million USD | -516.49% |
2008 Q4 | -235 Thousand USD | 91.46% |
2008 FY | -2.86 Million USD | -127.31% |
2008 Q2 | 661 Thousand USD | 221.96% |
2007 Q3 | 3.09 Million USD | 52.02% |
2007 Q4 | 3.62 Million USD | 17.21% |
2007 FY | 10.5 Million USD | 394.77% |
2007 Q1 | 1.75 Million USD | -75.33% |
2007 Q2 | 2.03 Million USD | 15.9% |
2006 Q1 | 1.1 Million USD | -80.95% |
2006 Q4 | 7.11 Million USD | 141.19% |
2006 Q3 | 2.95 Million USD | 132.6% |
2006 Q2 | -9.04 Million USD | -917.43% |
2006 FY | 2.12 Million USD | -84.62% |
2005 FY | 13.8 Million USD | 267.05% |
2005 Q4 | 5.81 Million USD | 52.85% |
2005 Q3 | 3.8 Million USD | 40.57% |
2005 Q2 | 2.7 Million USD | 81.97% |
2005 Q1 | 1.48 Million USD | -28.21% |
2004 FY | 3.76 Million USD | 21.06% |
2004 Q3 | 877 Thousand USD | 48.39% |
2004 Q1 | 221 Thousand USD | -84.04% |
2004 Q2 | 591 Thousand USD | 167.42% |
2004 Q4 | 2.07 Million USD | 136.03% |
2003 Q4 | 1.38 Million USD | 26.25% |
2003 Q2 | 695 Thousand USD | 0.0% |
2003 FY | 3.1 Million USD | 370.61% |
2003 Q3 | 1.09 Million USD | 57.84% |
2002 FY | 660 Thousand USD | -71.78% |
2001 FY | 2.33 Million USD | 125.55% |
2000 FY | 1.03 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Accelerate Diagnostics, Inc. | -61.61 Million USD | -164.262% |
BrainsWay Ltd. | -4.19 Million USD | -3779.747% |
Cerus Corporation | -37.48 Million USD | -334.349% |
Envoy Medical, Inc. | -29.9 Million USD | -444.446% |
electroCore, Inc. | -18.83 Million USD | -764.569% |
Helius Medical Technologies, Inc. | -8.85 Million USD | -1739.921% |
IceCure Medical Ltd | -14.65 Million USD | -1011.336% |
Inogen, Inc. | -102.44 Million USD | -58.941% |
OrthoPediatrics Corp. | -20.97 Million USD | -676.356% |
Lucid Diagnostics Inc. | -52.66 Million USD | -209.18% |
Monogram Orthopaedics, Inc. | -13.74 Million USD | -1084.652% |
MaxCyte, Inc. | -37.92 Million USD | -329.378% |
NeuroOne Medical Technologies Corporation | -11.85 Million USD | -1273.018% |
Nexalin Technology, Inc. | -4.64 Million USD | -3402.757% |
Orthofix Medical Inc. | -151.39 Million USD | -7.555% |
PAVmed Inc | -64.17 Million USD | -153.733% |
Rapid Micro Biosystems, Inc. | -52.46 Million USD | -210.353% |
RxSight, Inc. | -48.6 Million USD | -234.992% |
Sight Sciences, Inc. | -55.54 Million USD | -193.145% |
SI-BONE, Inc. | -43.33 Million USD | -275.745% |
TELA Bio, Inc. | -46.66 Million USD | -248.948% |
Treace Medical Concepts, Inc. | -49.52 Million USD | -228.776% |
Vivos Therapeutics, Inc. | -13.58 Million USD | -1098.8% |
Acutus Medical, Inc. | -81.66 Million USD | -99.396% |
Talis Biomedical Corporation | -62 Million USD | -162.604% |
Spectral AI, Inc. | -20.85 Million USD | -680.824% |
Nano-X Imaging Ltd. | -60.77 Million USD | -167.923% |
CVRx, Inc. | -41.19 Million USD | -295.235% |
DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 25534.867% |
PetVivo Holdings, Inc. | -10.95 Million USD | -1386.341% |
Bioventus Inc. | -156.23 Million USD | -4.226% |
Venus Concept Inc. | -37.25 Million USD | -337.136% |
TriSalus Life Sciences, Inc. | -59.03 Million USD | -175.81% |
LivaNova PLC | 17.54 Million USD | 1028.035% |
908 Devices Inc. | -36.39 Million USD | -347.356% |
Alphatec Holdings, Inc. | -186.63 Million USD | 12.755% |
Nemaura Medical Inc. | -14.14 Million USD | -1051.273% |
NeuroPace, Inc. | -32.95 Million USD | -394.092% |
LENSAR, Inc. | -14.38 Million USD | -1032.121% |
Apyx Medical Corporation | -18.71 Million USD | -770.16% |
STRATA Skin Sciences, Inc. | -10.83 Million USD | -1403.536% |
BioSig Technologies, Inc. | -29.04 Million USD | -460.7% |
Anika Therapeutics, Inc. | -82.66 Million USD | -96.975% |
ClearPoint Neuro, Inc. | -22.08 Million USD | -637.168% |
Integra LifeSciences Holdings Corporation | 67.74 Million USD | 340.376% |
Axonics, Inc. | -6.08 Million USD | -2574.655% |
Outset Medical, Inc. | -172.79 Million USD | 5.766% |
IRIDEX Corporation | -9.57 Million USD | -1601.494% |
PROCEPT BioRobotics Corporation | -105.89 Million USD | -53.765% |
IRadimed Corporation | 17.19 Million USD | 1047.101% |
Tivic Health Systems, Inc. | -8.24 Million USD | -1875.17% |
INVO Bioscience, Inc. | -8.03 Million USD | -1926.644% |
Telesis Bio, Inc. | -47.72 Million USD | -241.197% |
Viemed Healthcare, Inc. | 10.24 Million USD | 1689.7% |
Varex Imaging Corporation | -47.7 Million USD | -241.369% |
Quipt Home Medical Corp. | -2.78 Million USD | -5748.886% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -1342.788% |
Pulmonx Corporation | -60.84 Million USD | -167.628% |
Dynatronics Corporation | -2.69 Million USD | -5935.951% |
Modular Medical, Inc. | -17.47 Million USD | -832.072% |
ReShape Lifesciences Inc. | -11.38 Million USD | -1329.99% |
Semler Scientific, Inc. | 20.58 Million USD | 891.104% |
InMode Ltd. | 197.91 Million USD | 182.273% |
Bruker Corporation | 427.2 Million USD | 138.116% |
Cytosorbents Corporation | -28.5 Million USD | -471.196% |
DexCom, Inc. | 541.5 Million USD | 130.071% |
Align Technology, Inc. | 445.05 Million USD | 136.587% |
Viveve Medical, Inc. | -22.02 Million USD | -639.243% |
ZimVie Inc. | -393.28 Million USD | 58.596% |
Movano Inc. | -29.28 Million USD | -456.067% |
Cytek Biosciences, Inc. | -12.14 Million USD | -1240.41% |
Nexalin Technology, Inc. | -4.64 Million USD | -3402.757% |
DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 25534.867% |
Tandem Diabetes Care, Inc. | -222.61 Million USD | 26.853% |
Profound Medical Corp. | -28.56 Million USD | -469.964% |
Insulet Corporation | 206.3 Million USD | 178.93% |
enVVeno Medical Corporation | -23.51 Million USD | -592.435% |
Surmodics, Inc. | -11.54 Million USD | -1310.787% |
iCAD, Inc. | -4.84 Million USD | -3259.459% |
Nuwellis, Inc. | -20.2 Million USD | -705.745% |
Biotricity, Inc. | -14.09 Million USD | -1055.312% |
iRhythm Technologies, Inc. | -123.4 Million USD | -31.949% |
Aethlon Medical, Inc. | -12.2 Million USD | -1233.803% |
InspireMD, Inc. | -19.91 Million USD | -717.599% |
PAVmed Inc. | -64.17 Million USD | -153.733% |
BIOLASE, Inc. | -20.63 Million USD | -689.225% |
Beyond Air, Inc. | -60.24 Million USD | -170.298% |
FONAR Corporation | 10.56 Million USD | 1640.9% |
AxoGen, Inc. | -21.71 Million USD | -649.83% |
Vivani Medical, Inc. | -25.65 Million USD | -534.777% |
Tactile Systems Technology, Inc. | 28.51 Million USD | 671.043% |
Inari Medical, Inc. | -1.63 Million USD | -9853.117% |
UFP Technologies, Inc. | 44.92 Million USD | 462.463% |
QT Imaging Holdings, Inc. | -5.13 Million USD | -3072.69% |
Heart Test Laboratories, Inc. | -6.6 Million USD | -2365.221% |
Tenon Medical, Inc. | -15.58 Million USD | -945.074% |
Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -955.575% |
Co-Diagnostics, Inc. | -35.33 Million USD | -360.854% |
AdaptHealth Corp. | -678.89 Million USD | 76.015% |
Sintx Technologies, Inc. | -8.25 Million USD | -1871.583% |
NanoVibronix, Inc. | -3.71 Million USD | -4287.847% |
Quanterix Corporation | -32.33 Million USD | -403.597% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -1342.788% |
Sensus Healthcare, Inc. | 485 Thousand USD | 33673.814% |
Pacific Biosciences of California, Inc. | -306.73 Million USD | 46.914% |
TransMedics Group, Inc. | -25.02 Million USD | -550.603% |
ReWalk Robotics Ltd. | -22.13 Million USD | -635.702% |
NeuroMetrix, Inc. | -6.52 Million USD | -2393.81% |
Hyperfine, Inc. | -44.23 Million USD | -268.084% |
Establishment Labs Holdings Inc. | -78.5 Million USD | -107.425% |
Biomerica, Inc. | -5.97 Million USD | -2623.871% |
Bone Biologics Corporation | -8.94 Million USD | -1719.621% |
AVITA Medical, Inc. | -39.16 Million USD | -315.727% |
Bluejay Diagnostics, Inc. | -9.95 Million USD | -1535.873% |
Silk Road Medical, Inc | -55.74 Million USD | -192.114% |